La Jolla Pharmaceutical Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of La Jolla Pharmaceutical Company generated cash of $28,244,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,788,000 last year. Net change in cash is therefore $25,447,000.
Cash Flow
| 2012 | -2.13M | 0 | 500K |
|---|---|---|---|
| 2013 | -4.73M | -43K | 10.00M |
| 2014 | -12.87M | -258K | 53.06M |
| 2015 | -25.18M | -1.81M | 104.91M |
| 2016 | -58.67M | -2.21M | 149K |
| 2017 | -84.88M | -9.19M | 119.26M |
| 2018 | -152.36M | -2.34M | 236.39M |
| 2019 | -84.95M | -698K | 864K |
| 2020 | -37.64M | -30.94M | 1.11M |
| 2021 | 28.24M | -9K | -2.78M |
LJPC Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 21.26M | 88.72M | 173.51M | 91.82M | 65.72M | 126.46M | 48.55M | 8.62M | 3.40M | 5.04M |
Operating activities | ||||||||||
Net income | 19.66M | -39.42M | -116.50M | -199.46M | -114.80M | -78.18M | -41.91M | -21.31M | -17.93M | -7.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.88M | 4.08M | 4.55M | 4.40M | 1.26M | 730K | 347K | 17K | 5K | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.37M | 8.60M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.37M | 8.60M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.77M | -1.68M | -1.57M | -1.38M | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -1.11M | -1.49M | -191K | -2.02M | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -484K | -2.81M | -4.39M | -2.91M | 4.83M | 3.6M | 1.77M | -104K | 822K | -49K |
Cash generated by operating activities | 28.24M | -37.64M | -84.95M | -152.36M | -84.88M | -58.67M | -25.18M | -12.87M | -4.73M | -2.13M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -2.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -9K | 0 | -698K | -2.34M | -9.19M | -2.21M | -1.81M | -258K | -43K | 0 |
Acquisitions Net | 0 | -33.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -9K | -30.94M | -698K | -2.34M | -9.19M | -2.21M | -1.81M | -258K | -43K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 436K | 605K | 833K | 109.80M | 117.48M | 0 | 104.59M | 53.06M | 6.75M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -801K | 0 |
Repurchases of common stock | -3.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -2.78M | 1.11M | 864K | 236.39M | 119.26M | 149K | 104.91M | 53.06M | 10.00M | 500K |
Net Change In Cash | 25.44M | -67.46M | -84.78M | 81.68M | 25.18M | -60.74M | 77.91M | 39.92M | 5.22M | -1.63M |
Cash at end of period | 46.70M | 21.26M | 88.72M | 173.51M | 90.91M | 65.72M | 126.46M | 48.55M | 8.62M | 3.40M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |